StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$91.95+0.37 (+0.40%)

Close on Nov 17, 2026Market cap $5.97BP/E –Yield –

Mirum Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Mirum Pharmaceuticals's price to book ratio was 26.6× on Jul 31, 2026, against 11.0× a year earlier. Over the last 5 years it ranged from 4.1× to 29.4×, with a median of 8.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202626.6×+12.7
2025Dec 31, 202513.9×+5.3
2024Dec 31, 20248.5×+3.4
2023Dec 29, 20235.1×+0.9
2022Dec 30, 20224.2×−4.4
2021Dec 31, 20218.6×+4.9
2020Dec 31, 20203.7×−0.1
2019Dec 31, 20193.8×–

More Mirum Pharmaceuticals figures

See a number that looks wrong?